User profiles for Elisa Pin

Elisa Pin

SciLifeLab (Science for Life Laboratory), Dept Protein Science, KTH Royal Institute of …
Verified email at scilifelab.se
Cited by 1968

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

…, C Hellström, S Bayati, S Bergström, E Pin… - Nature …, 2020 - nature.com
SARS-CoV-2 may pose an occupational health risk to healthcare workers. Here, we report
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …

The role of proteomics in prostate cancer research: biomarker discovery and validation

E Pin, C Fredolini, EF Petricoin III - Clinical biochemistry, 2013 - Elsevier
PURPOSE: Prostate Cancer (PCa) represents the second most frequent type of tumor in
men worldwide. Incidence increases with patient age and represents the most important risk …

The human secretome

…, P Nilsson, A Månberg, T Dodig-Crnkovic, E Pin… - Science …, 2019 - science.org
The proteins secreted by human cells (collectively referred to as the secretome) are important
not only for the basic understanding of human biology but also for the identification of …

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

…, PM Mertes, S Kailasan, MJ Aman, E Pin… - Science translational …, 2022 - science.org
The drivers of critical coronavirus disease 2019 (COVID-19) remain unknown. Given major
confounding factors such as age and comorbidities, true mediators of this condition have …

Immunocapture strategies in translational proteomics

C Fredolini, S Byström, E Pin, F Edfors… - Expert review of …, 2016 - Taylor & Francis
Aiming at clinical studies of human diseases, antibody-assisted assays have been applied
to biomarker discovery and toward a streamlined translation from patient profiling to assays …

[HTML][HTML] Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2

…, M Gordon, AC Salomonsson, C Hellström, E Pin… - …, 2021 - thelancet.com
Background Recent reports demonstrate robust serological responses to a single dose of
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B-and T-cell immunity during 13 months in consecutive patients

…, S Mravinacova, S Muschiol, P Nilsson, M Palma, E Pin… - Leukemia, 2022 - nature.com
We studied clinical and immunological outcome of Covid-19 in consecutive CLL patients from
a well-defined area during month 1–13 of the pandemic. Sixty patients (median age 71 y, …

Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys

…, S Hober, A Månberg, P Nilsson, E Pin… - The Journal of …, 2021 - academic.oup.com
… in-house enzyme-linked immunosorbent assay (ELISA) for samples taken prior to June 2020
(… Elecsys and the in-house ELISA determine antibodies against recombinant nucleocapsid …

Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic …

C Lindblad, E Pin, D Just, F Al Nimer, P Nilsson… - Critical Care, 2021 - Springer
Background Severe traumatic brain injury (TBI) is associated with blood–brain barrier (BBB)
disruption and a subsequent neuroinflammatory process. We aimed to perform a multiplex …

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

…, J Olofsson, L Skoglund, J Yousef, E Pin… - Journal of internal …, 2022 - Wiley Online Library
Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …